.png){kind=logo}
Weight loss that works with your biology
Sequence addresses the biological factors that can prevent weight loss.
*Based on a 68-week clinical trial, patients without diabetes but with a BMI of ≥30, or ≥27 lost an average of 15% of their body weight (-33.6 lbs) on 2.4 mg semaglutide, when combined with a reduced-calorie diet and increased physical activity. Wegovy® is FDA-approved for weight management.
GLP-1s: The Next Generation of Treatments
At-home weight loss program, start in 5 minutes
Take our 5-minute quiz
Meet your Clinician
Receive your medication
Start your program
Just $49 for your first month
* Your Sequence program includes the cost of labs and non-GLP-1 medications. The cost of GLP-1 medications is subject to insurance coverage. Your Care Team will help you with insurance coverage.
A new kind of weight loss program
Prescription Care
Insurance Coordinator
Nutrition plan
Fitness plan
Clinician check-ins
Companion app
A new generation of weight management treatments
*Statements reference the GLP-1 class of medications
Expert clinicians who care
Real-world weight loss success
“I actually feel like the medication is working! My appetite has gone down significantly so it’s been great”
Yaaseen H.
“I don’t have the cravings for sweets & I’m not as hungry anymore. I am so excited!”
Stephanie K.
“YOLO! I have lost 13 lbs since starting the medicine! Thank you!!!”
Berta A.
“I’ve hit my lowest weight in 3 years — I’m finally back in the right direction”
Kimberly W.
“It completely curbs my appetite and cravings. I’ve lost 5 lbs already. This is the greatest hope I’ve had in a long time.”
Naomi K.
“I have lost 30 pounds and reversed prediabetes. All because of this program.”
Monica M.
Ready to lose weight?
Join the Community
Subscribe to our newsletter
